|
|
||||||||
Production1
North Shore University Hospital/New York University School of Medicine, Manhasset, NY 11030
Recent in vitro studies have suggested that CD14, a major receptor
for LPS, may also be a receptor for cell wall components of
Gram-positive bacteria and thus play a role in Gram-positive shock. To
analyze the in vivo role of CD14 in responses to Gram-positive
bacteria, CD14-deficient and control mice were injected with
Staphylococcus aureus, and the effects on lethality,
bacterial clearance, and production of cytokines were analyzed.
Survival of CD14-deficient and control mice did not differ
significantly after administration of various doses of either
unencapsulated or encapsulated S. aureus; furthermore,
mice in both groups displayed similar symptoms of shock. In addition,
inflammatory cytokines such as TNF-
and IL-6 were readily detectable
in the serum of CD14-deficient mice injected with live or
antibiotic-killed S. aureus. Surprisingly, the serum
concentration of TNF-
in CD14-deficient mice was at least threefold
higher than in control mice after injection of either unencapsulated or
encapsulated S. aureus, suggesting that CD14
down-regulates TNF-
. A similar increase in serum TNF-
occurred
when CD14-deficient animals were injected with gentamicin-killed
bacteria even though no symptoms of shock were observed. These studies
indicate that CD14, in contrast to its key function in responses to the
Gram-negative bacterium, Escherichia coli 0111, does not
play a prominent role in septic shock induced by S.
aureus, and that the symptoms of S. aureus shock
are not due solely to TNF-
.
This article has been cited by other articles:
![]() |
M. Leendertse, R. J. L. Willems, I. A. J. Giebelen, P. S. van den Pangaart, W. J. Wiersinga, A. F. de Vos, S. Florquin, M. J. M. Bonten, and T. van der Poll TLR2-Dependent MyD88 Signaling Contributes to Early Host Defense in Murine Enterococcus faecium Peritonitis J. Immunol., April 1, 2008; 180(7): 4865 - 4874. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dessing, S. Knapp, S. Florquin, A. F. de Vos, and T. van der Poll CD14 Facilitates Invasive Respiratory Tract Infection by Streptococcus pneumoniae Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 604 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Echchannaoui, K. Frei, M. Letiembre, R. M. Strieter, Y. Adachi, and R. Landmann CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection J. Leukoc. Biol., September 1, 2005; 78(3): 705 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fournier and D. J. Philpott Recognition of Staphylococcus aureus by the Innate Immune System Clin. Microbiol. Rev., July 1, 2005; 18(3): 521 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Knuefermann, Y. Sakata, J. S. Baker, C.-H. Huang, K. Sekiguchi, H. S. Hardarson, O. Takeuchi, S. Akira, and J. G. Vallejo Toll-Like Receptor 2 Mediates Staphylococcus aureus-Induced Myocardial Dysfunction and Cytokine Production in the Heart Circulation, December 14, 2004; 110(24): 3693 - 3698. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsujimoto, S. Ono, S. Hiraki, T. Majima, N. Kawarabayashi, H. Sugasawa, M. Kinoshita, H. Hiraide, and H. Mochizuki Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+CD14 + monocytes in patients with septic shock Innate Immunity, August 1, 2004; 10(4): 229 - 237. [Abstract] [PDF] |
||||
![]() |
E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Lee, M. J. Paape, T. H. Elsasser, and X. Zhao Recombinant Soluble CD14 Reduces Severity of Intramammary Infection by Escherichia coli Infect. Immun., July 1, 2003; 71(7): 4034 - 4039. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Su, S. M. Goyert, M.-H. Fan, A. Aminlari, K. Q. Gong, R. D. Klein, A. Myc, W. H. Alarcon, L. Steinstraesser, D. G. Remick, et al. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14 Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G640 - G645. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Neilsen, G. A. Zimmerman, and T. M. McIntyre Escherichia coli Braun Lipoprotein Induces a Lipopolysaccharide-Like Endotoxic Response from Primary Human Endothelial Cells J. Immunol., November 1, 2001; 167(9): 5231 - 5239. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rabehi, T. Irinopoulou, B. Cholley, N. Haeffner-Cavaillon, and M.-P. Carreno Gram-Positive and Gram-Negative Bacteria Do Not Trigger Monocytic Cytokine Production through Similar Intracellular Pathways Infect. Immun., July 1, 2001; 69(7): 4590 - 4599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Jorgensen, J. E. Wang, M. Almlof, C. Thiemermann, S. J. Foster, R. Solberg, and A. O. Aasen Peptidoglycan and Lipoteichoic Acid Modify Monocyte Phenotype in Human Whole Blood Clin. Vaccine Immunol., May 1, 2001; 8(3): 515 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ebong, S. M. Goyert, J. A. Nemzek, J. Kim, G. L. Bolgos, and D. G. Remick Critical Role of CD14 for Production of Proinflammatory Cytokines and Cytokine Inhibitors during Sepsis with Failure To Alter Morbidity or Mortality Infect. Immun., April 1, 2001; 69(4): 2099 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yin, B. U. Bradford, M. D. Wheeler, T. Uesugi, M. Froh, S. M. Goyert, and R. G. Thurman Reduced Early Alcohol-Induced Liver Injury in CD14-Deficient Mice J. Immunol., April 1, 2001; 166(7): 4737 - 4742. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Verbon, P. E. P. Dekkers, T. ten Hove, C. E. Hack, J. P. Pribble, T. Turner, S. Souza, T. Axtelle, F. J. Hoek, S. J. H. van Deventer, et al. IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans J. Immunol., March 1, 2001; 166(5): 3599 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dziarski and D. Gupta Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes Innate Immunity, October 1, 2000; 6(5): 401 - 405. [Abstract] [PDF] |
||||
![]() |
M. Miettinen, A. Lehtonen, I. Julkunen, and S. Matikainen Lactobacilli and Streptococci Activate NF-{kappa}B and STAT Signaling Pathways in Human Macrophages J. Immunol., April 1, 2000; 164(7): 3733 - 3740. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |